ABSTRACT
Anaphylaxis [2] [2] [2]
Angioedema [1] [1] [3] (15%)
Dermatitis [1] [4] [1] (25%)
Edema • [5] (55%)
Erythema multiforme • [1]
Exanthems [3] [1] [5] (<5%)
Facial edema • [2] (3-20%)
Fixed eruption [1] [2] [6]
Hypersensitivity [2] [2] [3] (<10%)
Jarisch-Herxheimer reaction [2] [1]
Pruritus [2] [1] • [1] (3-20%)
Purpura [3] [1] (3-20%)
Pustules [1] • [1]
Rash [4] (2-10%)
[2] [3] [3] (28%)
SDRIFE [1] [2]
Serum sickness [1] [1]
Stevens-Johnson syndrome [6] [1] [8]
Toxic epidermal necrolysis • [4] [7]
Toxicity [1] [1]
Urticaria [2] [1] [4]
Vasculitis [1] [3] [1] [2]
HAIR
Alopecia [1] [1]
MUCOSAL
Gingival hyperplasia/hypertrophy [1] [1] [1] (3-20%)
Oral candidiasis • • (<10%) (3-20%)
Oral ulceration [1] [8] (24%)
Stomatitis • [1] [1] (3-20%)
A Azithromycin; C Clarithromycin; E Erythromycin; S Sirolimus
